Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Rumi Kihara"'
Autor:
Atsuo Tahara, Eiji Kurosaki, Masanori Yokono, Daisuke Yamajuku, Rumi Kihara, Yuka Hayashizaki, Toshiyuki Takasu, Masakazu Imamura, Li Qun, Hiroshi Tomiyama, Yoshinori Kobayashi, Atsushi Noda, Masao Sasamata, Masayuki Shibasaki
Publikováno v:
Journal of Pharmacological Sciences, Vol 120, Iss 1, Pp 36-44 (2012)
Sodium-glucose cotransporter (SGLT) 2 plays an important role in renal glucose reabsorption, and inhibition of renal SGLT2 activity represents an innovative strategy for the treatment of hyperglycemia in diabetic patients. The present study investiga
Externí odkaz:
https://doaj.org/article/7343cab4fe994577b817d84f0d252634
Autor:
Sadao Kuromitsu, Masaaki Hirano, Tadashi Terasaka, Nobuaki Shindoh, Minoru Kameda, Tomoyuki Suzuki, Ayako Nakayama, Tatsuya Kawase, Rumi Kihara, Hidetsugu Okada, Takashi Futami
Supplementary Figure legend. Supplementary Table S1. Kinase inhibitory profile of ASP5878
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0510604a9f3ffc410db813c90c8887cd
https://doi.org/10.1158/1535-7163.22508230
https://doi.org/10.1158/1535-7163.22508230
Autor:
Sadao Kuromitsu, Masaaki Hirano, Tadashi Terasaka, Nobuaki Shindoh, Minoru Kameda, Tomoyuki Suzuki, Ayako Nakayama, Tatsuya Kawase, Rumi Kihara, Hidetsugu Okada, Takashi Futami
ASP5878 inhibited activation of FGFR signals in MDA-MB-453 xenograft model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321fb24799781c93cc0df30eb911db3f
https://doi.org/10.1158/1535-7163.22508227.v1
https://doi.org/10.1158/1535-7163.22508227.v1
Autor:
Tadashi Terasaka, Sadao Kuromitsu, Ayako Nakayama, Tatsuya Kawase, Minoru Kameda, Nobuaki Shindoh, Takashi Futami, Rumi Kihara, Tomoyuki Suzuki, Hidetsugu Okada, Masaaki Hirano
Publikováno v:
Molecular Cancer Therapeutics. 16:68-75
Hepatocellular carcinoma is an aggressive cancer with poor prognosis. Fibroblast growth factor 19, a member of the fibroblast growth factor family, is a ligand for fibroblast growth factor receptor 4. Moreover, it plays a crucial role in the progress
Autor:
Nobuaki Shindoh, Rumi Kihara, Takashi Futami, Makoto Asaumi, Sadao Kuromitsu, Kenichi Mori, Tatsuya Kawase
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Gastric cancer remains one of the leading causes of cancer death worldwide. Despite intensive investigations of treatments over the past three decades, the poor prognosis of patients with unresectable advanced or recurrent gastric cancer has not sign
Autor:
Yuka Hayashizaki, Yasuo Uchiyama, Keisuke Mitsuoka, Masao Sasamata, Hiroshi Tomiyama, Atsuo Tahara, Eiji Kurosaki, Rumi Kihara, Sousuke Miyoshi, Yuko Muramatsu, Masanori Yokono, Qun Li, Masayuki Shibasaki, Toshiyuki Takasu
Publikováno v:
European Journal of Pharmacology. 727:66-74
Ipragliflozin is a novel and selective sodium-glucose cotransporter 2 (SGLT2) inhibitor that induces sustained increases in urinary glucose excretion by inhibiting renal glucose reabsorption and thereby exerting a subsequent antihyperglycemic effect.
Autor:
Masao Sasamata, Daisuke Yamajuku, Atsuo Tahara, Masanori Yokono, Yoshinori Kobayashi, Rumi Kihara, Qun Li, Toshiyuki Takasu, Masakazu Imamura, Eiji Kurosaki, Hiroshi Tomiyama, Yuka Hayashizaki, Masayuki Shibasaki, Atsushi Noda
Publikováno v:
European Journal of Pharmacology. 715:246-255
The sodium-glucose cotransporter 2 (SGLT2) is responsible for most glucose reabsorption in the kidney and has been proposed as a novel therapeutic target for the treatment of type 2 diabetes. In the present study, the therapeutic effects of SGLT2 sel
Autor:
Hiroshi Tomiyama, Masayuki Shibasaki, Rumi Kihara, Atsuo Tahara, Atsushi Noda, Masakazu Imamura, Masanori Yokono, Yoshinori Kobayashi, Eiji Kurosaki, Daisuke Yamajuku
Publikováno v:
Endocrine Research. 38:168-183
Background and aim. Sodium-glucose cotransporter (SGLT) 2 is a specifically expressed transporter in the kidney that plays an important role in renal glucose reabsorption, and its inhibition may present a novel therapeutic strategy for treating diabe
Autor:
Masao Sasamata, Hiroshi Tomiyama, Toshiyuki Takasu, Yoshinori Kobayashi, Atsuo Tahara, Daisuke Yamajuku, Eiji Kurosaki, Rumi Kihara, Masayuki Shibasaki, Masakazu Imamura, Yuka Hayashizaki, Li Qun, Atsushi Noda, Masanori Yokono
Publikováno v:
Journal of Pharmacological Sciences, Vol 120, Iss 1, Pp 36-44 (2012)
Sodium-glucose cotransporter (SGLT) 2 plays an important role in renal glucose reabsorption, and inhibition of renal SGLT2 activity represents an innovative strategy for the treatment of hyperglycemia in diabetic patients. The present study investiga
Autor:
Rumi Kihara, Atsuo Tahara, Daisuke Yamajuku, Hiroshi Tomiyama, Eiji Kurosaki, Yoshinori Kobayashi, Yuka Hayashizaki, Masayuki Shibasaki, Toshiyuki Takasu, Masakazu Imamura, Masanori Yokono, Atsushi Noda, Masao Sasamata, Li Qun
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 385:423-436
The pharmacological profile of ipragliflozin (ASP1941; (1S)-1,5-anhydro-1-C-{3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl}-D: -glucitol compound with L: -proline (1:1)), a novel SGLT2 selective inhibitor, was investigated. In vitro, the potency of